SCHEMBL20919699

SCHEMBL20919699

CCc1ncc(NC(=O)C2(c3ccc(-c4ccnc(C(=O)NC)c4)cc3)CCC2)cn1

nearest known ligand 0.42

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 5/20 0.42
CYP2C9 P11712 1/20 0.42
HDAC1 Q13547 11/20 0.41
HDAC3 O15379 2/20 0.39
HDAC7 Q8WUI4 2/20 0.39
HDAC2 Q92769 2/20 0.39
HDAC8 Q9BY41 2/20 0.39
KDR P35968 2/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20919670 0.86 HDAC1 (0.43) IDO1CYP2C9HDAC1HDAC3HDAC7
SCHEMBL20919675 0.83 ALDH1A1 (0.58) IDO1HDAC1HDAC3HDAC7HDAC2
SCHEMBL20919709 0.81 IDO1 (0.41) IDO1CYP2C9HDAC1HDAC3HDAC7
SCHEMBL20919737 0.80 FFAR2 (0.43) IDO1HDAC1HDAC3HDAC7HDAC2
SCHEMBL20919736 0.80 IDO1 (0.43) IDO1CYP2C9HDAC1HDAC3HDAC7
SCHEMBL20919941 0.80 HDAC1 (0.42) IDO1CYP2C9HDAC1HDAC3HDAC7
SCHEMBL20919682 0.80 HDAC1 (0.44) IDO1HDAC1HDAC3HDAC7HDAC2
SCHEMBL20938113 0.80 HDAC1 (0.44) IDO1HDAC1HDAC3HDAC7HDAC2
SCHEMBL20919702 0.80 FFAR2 (0.44) IDO1HDAC1KDRALDH1A1LMNA
SCHEMBL20919680 0.79 ALDH1A1 (0.60) IDO1HDAC1HDAC3HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3735410-A1 PICOLINAMIDE COMPOUNDS Tempest Therapeutics, Inc. (US) 2020-11-11 EP claimed
WO-2019079614-A1 PICOLINAMIDE COMPOUNDS TEMPEST THERAPEUTICS, INC. (US) 2019-04-25 WO claimed
EP-3735410-A1 PICOLINAMIDE COMPOUNDS Tempest Therapeutics, Inc. (US) 2020-11-11 EP disclosed
WO-2019079614-A1 PICOLINAMIDE COMPOUNDS TEMPEST THERAPEUTICS, INC. (US) 2019-04-25 WO disclosed